From Genetics to Biomarkers and Therapeutic Hypotheses in Psychiatric Disorders
Time: 2:00 pm
day: Day Two Track A - PM
Details:
- Reviewing how genetics and multi-omics are being pursued for neuropsychiatric drug development
- Drawing conclusions from large-scale genetics to inform new therapeutic targets
- Showcasing emerging evidence for CSF biomarkers in schizophrenia and bipolar that may correlate with cognitive decline
